PCSK9 Inhibitors & Statins

In May 2014, two doctors were maliciously attacked by a researcher. The researcher heads up the Clinical Trial Service Unit (CTSU) at Oxford University.

The doctors’ crimes (they were independent, but the same) were to mention that statin side effects might affect approximately 18-20% of takers. Both doctors referenced a peer reviewed article, which said that “the rate of reported statin-related events to statins was nearly 18%.”(The researcher demanded a retraction of both articles and continues to want the journal editor’s head on a plate, so to speak.

Read Article by Dr. Zoe Harcombe.